SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-21-015664
Filing Date
2021-03-16
Accepted
2021-03-16 15:22:01
Documents
103
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 20-F f20f2020a1_purplebiotech.htm 20-F/A 2862612
2 CERTIFICATION f20f2020a1ex12-1_purple.htm EX-12.1 9727
3 CERTIFICATION f20f2020a1ex12-2_purple.htm EX-12.2 10680
4 CERTIFICATION f20f2020a1ex13-1_purple.htm EX-13.1 4215
5 CERTIFICATION f20f2020a1ex13-2_purple.htm EX-13.2 4186
6 GRAPHIC img_001.jpg GRAPHIC 17259
7 GRAPHIC img_002.jpg GRAPHIC 31866
8 GRAPHIC img_003.jpg GRAPHIC 12894
  Complete submission text file 0001213900-21-015664.txt   8330847

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE ppbt-20201231.xml EX-101.INS 1410468
10 XBRL SCHEMA FILE ppbt-20201231.xsd EX-101.SCH 106786
11 XBRL CALCULATION FILE ppbt-20201231_cal.xml EX-101.CAL 75321
12 XBRL DEFINITION FILE ppbt-20201231_def.xml EX-101.DEF 247999
13 XBRL LABEL FILE ppbt-20201231_lab.xml EX-101.LAB 498225
14 XBRL PRESENTATION FILE ppbt-20201231_pre.xml EX-101.PRE 370843
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-37643 | Film No.: 21745388
SIC: 2834 Pharmaceutical Preparations